Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Operating expenses:
Research and development	$ 43,902	$ 29,109	$ 74,526	$ 58,992
General and administrative	3,962	4,421	8,211	8,877
Total operating expenses	47,864	33,530	82,737	67,869
Loss from operations	(47,864)	(33,530)	(82,737)	(67,869)
Other income:
Interest income	4,042	3,108	8,566	6,460
Other income (loss)	38	40	(2)	57
Total other income	4,080	3,148	8,564	6,517
Net loss	$ (43,784)	$ (30,382)	$ (74,173)	$ (61,352)
Net loss per share, basic (in dollars per share)	$ (0.51)	$ (0.54)	$ (0.87)	$ (1.1)
Net loss per share, diluted (in dollars per share)	$ (0.51)	$ (0.54)	$ (0.87)	$ (1.1)
Weighted average shares used to compute net loss per share, basic (in shares)	85,497,426	56,282,402	85,462,021	55,928,363
Weighted average shares used to compute net loss per share, diluted (in shares)	85,497,426	56,282,402	85,462,021	55,928,363